US-Venezuela Tensions Simmer At World Health Assembly, While Global Community Scales Up Emergency Medical Aid 26/05/2019 John Zarocostas Mounting political tensions between the United States and the embattled Venezuelan government of President Nicolás Maduro, including a proliferation of crippling US sanctions, are being played out in the halls of the 72nd World Health Assembly, marred by walkouts and finger-pointing by the two adversaries. Image Credits: WHO/PAHO, John Zarocostas. Continue reading -> Global Accelerator Network On Antibacterial Research Expands 26/02/2019 William New A network of life sciences organisations working together to address antibacterial resistance worldwide has expanded to now include 10 top organisations from six countries, according to CARB-X (Combating Antibiotic Resistant Bacteria), a US-based partnership investing hundreds of millions of dollars in R&D for antibacterial resistance over 5 years. Continue reading -> New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> Over-The-Counter Oral Contraceptive Pill: Implications For Women’s Health – And For Policy 14/12/2018 Varuna Srinivasan The US Food and Drug Administration (FDA) is considering approval of a first of its kind over-the-counter oral contraceptive pill, submitted by two organisations that are campaigning for its acceptance. But looming changes in policy, coverage and patient protection could provide barriers to its access and use. Continue reading -> Abortion In The Context Of The US Midterm Elections: Global Impact 02/11/2018 Varuna Srinivasan WASHINGTON, DC -- The United States is one of the biggest funders of reproductive health and family planning in multiple developing countries. It is also one of the biggest distributors of contraceptive services in the international market providing all but one: Abortion. The US congressional midterm elections taking place on 6 November could influence further proposed changes to these policies by the current US administration, potentially affecting the lives of millions of women worldwide, for better or worse. Continue reading -> US Releases New Medicare Drug Plan To “Pay The Prices Other Countries Pay” 26/10/2018 David Branigan The United States Department of Health and Human Services has released a new plan intended to reduce drug prices for some patients on Medicare, based on an international pricing index model. In his announcement of the plan, President Trump said the US would save money “for our seniors by paying the prices other countries pay. Nothing special, just the prices that other countries pay.” Continue reading -> Political Views And Vaccine Refusal Rates An Increasing Concern For Policymakers And Public Health Officials 13/07/2018 Tatum Anderson Or they should be. That’s the conclusion of a recent study published in the medical journal Vaccine. The study focused on political views of parents in the state of California, who had chosen not to vaccinate their nursery-school aged children. And it tracked the number of parents who had filed personal belief exemptions (PBEs), applications for permission to avoid vaccinations over a 5-year period to 2015. A disproportionate number of parents filing such forms were from Republican or conservative neighbourhoods, according to researcher Kevin A Estep, from the health administration and policy program at the university. Continue reading -> First Results Of Pharma-Led Initiative To Increase Access To Treatments 29/06/2018 Catherine Saez Early results of a biopharmaceutical companies-based initiative to encourage access to treatment in developing countries shows a focus on cancer, diabetes, and cardiovascular disease, through 62 programmes. The report, conducted by an independent observatory, provides key findings on several areas, including local priorities, and social inequity. Continue reading -> CDC Director Redfield: Long-Term Investment In Global Health Security Most Critical 14/06/2018 William New WASHINGTON, DC -- Recently named director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield told a gathering of global health experts this week that the most critical investment that can be made is in global health security, with the recent fast response to the Ebola outbreak in the Democratic Republic of the Congo setting the example. Continue reading -> Trump Declares Intent To Stop Pharma Companies From ‘Gaming’ Patent System 11/05/2018 William New US President Trump today declared in a White House speech his intent to "take steps" to lower drug prices by stopping "gaming of regulatory and patent processes by drug makers to unfairly protect monopolies," as well as increasing price transparency and promoting biosimilars and generics. But to do this, his administration will take on what it sees as "freeloading" on US innovation by foreign governments, and addressing "unfair" intellectual property and market access policies in trade agreements. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Global Accelerator Network On Antibacterial Research Expands 26/02/2019 William New A network of life sciences organisations working together to address antibacterial resistance worldwide has expanded to now include 10 top organisations from six countries, according to CARB-X (Combating Antibiotic Resistant Bacteria), a US-based partnership investing hundreds of millions of dollars in R&D for antibacterial resistance over 5 years. Continue reading -> New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> Over-The-Counter Oral Contraceptive Pill: Implications For Women’s Health – And For Policy 14/12/2018 Varuna Srinivasan The US Food and Drug Administration (FDA) is considering approval of a first of its kind over-the-counter oral contraceptive pill, submitted by two organisations that are campaigning for its acceptance. But looming changes in policy, coverage and patient protection could provide barriers to its access and use. Continue reading -> Abortion In The Context Of The US Midterm Elections: Global Impact 02/11/2018 Varuna Srinivasan WASHINGTON, DC -- The United States is one of the biggest funders of reproductive health and family planning in multiple developing countries. It is also one of the biggest distributors of contraceptive services in the international market providing all but one: Abortion. The US congressional midterm elections taking place on 6 November could influence further proposed changes to these policies by the current US administration, potentially affecting the lives of millions of women worldwide, for better or worse. Continue reading -> US Releases New Medicare Drug Plan To “Pay The Prices Other Countries Pay” 26/10/2018 David Branigan The United States Department of Health and Human Services has released a new plan intended to reduce drug prices for some patients on Medicare, based on an international pricing index model. In his announcement of the plan, President Trump said the US would save money “for our seniors by paying the prices other countries pay. Nothing special, just the prices that other countries pay.” Continue reading -> Political Views And Vaccine Refusal Rates An Increasing Concern For Policymakers And Public Health Officials 13/07/2018 Tatum Anderson Or they should be. That’s the conclusion of a recent study published in the medical journal Vaccine. The study focused on political views of parents in the state of California, who had chosen not to vaccinate their nursery-school aged children. And it tracked the number of parents who had filed personal belief exemptions (PBEs), applications for permission to avoid vaccinations over a 5-year period to 2015. A disproportionate number of parents filing such forms were from Republican or conservative neighbourhoods, according to researcher Kevin A Estep, from the health administration and policy program at the university. Continue reading -> First Results Of Pharma-Led Initiative To Increase Access To Treatments 29/06/2018 Catherine Saez Early results of a biopharmaceutical companies-based initiative to encourage access to treatment in developing countries shows a focus on cancer, diabetes, and cardiovascular disease, through 62 programmes. The report, conducted by an independent observatory, provides key findings on several areas, including local priorities, and social inequity. Continue reading -> CDC Director Redfield: Long-Term Investment In Global Health Security Most Critical 14/06/2018 William New WASHINGTON, DC -- Recently named director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield told a gathering of global health experts this week that the most critical investment that can be made is in global health security, with the recent fast response to the Ebola outbreak in the Democratic Republic of the Congo setting the example. Continue reading -> Trump Declares Intent To Stop Pharma Companies From ‘Gaming’ Patent System 11/05/2018 William New US President Trump today declared in a White House speech his intent to "take steps" to lower drug prices by stopping "gaming of regulatory and patent processes by drug makers to unfairly protect monopolies," as well as increasing price transparency and promoting biosimilars and generics. But to do this, his administration will take on what it sees as "freeloading" on US innovation by foreign governments, and addressing "unfair" intellectual property and market access policies in trade agreements. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> Over-The-Counter Oral Contraceptive Pill: Implications For Women’s Health – And For Policy 14/12/2018 Varuna Srinivasan The US Food and Drug Administration (FDA) is considering approval of a first of its kind over-the-counter oral contraceptive pill, submitted by two organisations that are campaigning for its acceptance. But looming changes in policy, coverage and patient protection could provide barriers to its access and use. Continue reading -> Abortion In The Context Of The US Midterm Elections: Global Impact 02/11/2018 Varuna Srinivasan WASHINGTON, DC -- The United States is one of the biggest funders of reproductive health and family planning in multiple developing countries. It is also one of the biggest distributors of contraceptive services in the international market providing all but one: Abortion. The US congressional midterm elections taking place on 6 November could influence further proposed changes to these policies by the current US administration, potentially affecting the lives of millions of women worldwide, for better or worse. Continue reading -> US Releases New Medicare Drug Plan To “Pay The Prices Other Countries Pay” 26/10/2018 David Branigan The United States Department of Health and Human Services has released a new plan intended to reduce drug prices for some patients on Medicare, based on an international pricing index model. In his announcement of the plan, President Trump said the US would save money “for our seniors by paying the prices other countries pay. Nothing special, just the prices that other countries pay.” Continue reading -> Political Views And Vaccine Refusal Rates An Increasing Concern For Policymakers And Public Health Officials 13/07/2018 Tatum Anderson Or they should be. That’s the conclusion of a recent study published in the medical journal Vaccine. The study focused on political views of parents in the state of California, who had chosen not to vaccinate their nursery-school aged children. And it tracked the number of parents who had filed personal belief exemptions (PBEs), applications for permission to avoid vaccinations over a 5-year period to 2015. A disproportionate number of parents filing such forms were from Republican or conservative neighbourhoods, according to researcher Kevin A Estep, from the health administration and policy program at the university. Continue reading -> First Results Of Pharma-Led Initiative To Increase Access To Treatments 29/06/2018 Catherine Saez Early results of a biopharmaceutical companies-based initiative to encourage access to treatment in developing countries shows a focus on cancer, diabetes, and cardiovascular disease, through 62 programmes. The report, conducted by an independent observatory, provides key findings on several areas, including local priorities, and social inequity. Continue reading -> CDC Director Redfield: Long-Term Investment In Global Health Security Most Critical 14/06/2018 William New WASHINGTON, DC -- Recently named director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield told a gathering of global health experts this week that the most critical investment that can be made is in global health security, with the recent fast response to the Ebola outbreak in the Democratic Republic of the Congo setting the example. Continue reading -> Trump Declares Intent To Stop Pharma Companies From ‘Gaming’ Patent System 11/05/2018 William New US President Trump today declared in a White House speech his intent to "take steps" to lower drug prices by stopping "gaming of regulatory and patent processes by drug makers to unfairly protect monopolies," as well as increasing price transparency and promoting biosimilars and generics. But to do this, his administration will take on what it sees as "freeloading" on US innovation by foreign governments, and addressing "unfair" intellectual property and market access policies in trade agreements. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Over-The-Counter Oral Contraceptive Pill: Implications For Women’s Health – And For Policy 14/12/2018 Varuna Srinivasan The US Food and Drug Administration (FDA) is considering approval of a first of its kind over-the-counter oral contraceptive pill, submitted by two organisations that are campaigning for its acceptance. But looming changes in policy, coverage and patient protection could provide barriers to its access and use. Continue reading -> Abortion In The Context Of The US Midterm Elections: Global Impact 02/11/2018 Varuna Srinivasan WASHINGTON, DC -- The United States is one of the biggest funders of reproductive health and family planning in multiple developing countries. It is also one of the biggest distributors of contraceptive services in the international market providing all but one: Abortion. The US congressional midterm elections taking place on 6 November could influence further proposed changes to these policies by the current US administration, potentially affecting the lives of millions of women worldwide, for better or worse. Continue reading -> US Releases New Medicare Drug Plan To “Pay The Prices Other Countries Pay” 26/10/2018 David Branigan The United States Department of Health and Human Services has released a new plan intended to reduce drug prices for some patients on Medicare, based on an international pricing index model. In his announcement of the plan, President Trump said the US would save money “for our seniors by paying the prices other countries pay. Nothing special, just the prices that other countries pay.” Continue reading -> Political Views And Vaccine Refusal Rates An Increasing Concern For Policymakers And Public Health Officials 13/07/2018 Tatum Anderson Or they should be. That’s the conclusion of a recent study published in the medical journal Vaccine. The study focused on political views of parents in the state of California, who had chosen not to vaccinate their nursery-school aged children. And it tracked the number of parents who had filed personal belief exemptions (PBEs), applications for permission to avoid vaccinations over a 5-year period to 2015. A disproportionate number of parents filing such forms were from Republican or conservative neighbourhoods, according to researcher Kevin A Estep, from the health administration and policy program at the university. Continue reading -> First Results Of Pharma-Led Initiative To Increase Access To Treatments 29/06/2018 Catherine Saez Early results of a biopharmaceutical companies-based initiative to encourage access to treatment in developing countries shows a focus on cancer, diabetes, and cardiovascular disease, through 62 programmes. The report, conducted by an independent observatory, provides key findings on several areas, including local priorities, and social inequity. Continue reading -> CDC Director Redfield: Long-Term Investment In Global Health Security Most Critical 14/06/2018 William New WASHINGTON, DC -- Recently named director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield told a gathering of global health experts this week that the most critical investment that can be made is in global health security, with the recent fast response to the Ebola outbreak in the Democratic Republic of the Congo setting the example. Continue reading -> Trump Declares Intent To Stop Pharma Companies From ‘Gaming’ Patent System 11/05/2018 William New US President Trump today declared in a White House speech his intent to "take steps" to lower drug prices by stopping "gaming of regulatory and patent processes by drug makers to unfairly protect monopolies," as well as increasing price transparency and promoting biosimilars and generics. But to do this, his administration will take on what it sees as "freeloading" on US innovation by foreign governments, and addressing "unfair" intellectual property and market access policies in trade agreements. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Abortion In The Context Of The US Midterm Elections: Global Impact 02/11/2018 Varuna Srinivasan WASHINGTON, DC -- The United States is one of the biggest funders of reproductive health and family planning in multiple developing countries. It is also one of the biggest distributors of contraceptive services in the international market providing all but one: Abortion. The US congressional midterm elections taking place on 6 November could influence further proposed changes to these policies by the current US administration, potentially affecting the lives of millions of women worldwide, for better or worse. Continue reading -> US Releases New Medicare Drug Plan To “Pay The Prices Other Countries Pay” 26/10/2018 David Branigan The United States Department of Health and Human Services has released a new plan intended to reduce drug prices for some patients on Medicare, based on an international pricing index model. In his announcement of the plan, President Trump said the US would save money “for our seniors by paying the prices other countries pay. Nothing special, just the prices that other countries pay.” Continue reading -> Political Views And Vaccine Refusal Rates An Increasing Concern For Policymakers And Public Health Officials 13/07/2018 Tatum Anderson Or they should be. That’s the conclusion of a recent study published in the medical journal Vaccine. The study focused on political views of parents in the state of California, who had chosen not to vaccinate their nursery-school aged children. And it tracked the number of parents who had filed personal belief exemptions (PBEs), applications for permission to avoid vaccinations over a 5-year period to 2015. A disproportionate number of parents filing such forms were from Republican or conservative neighbourhoods, according to researcher Kevin A Estep, from the health administration and policy program at the university. Continue reading -> First Results Of Pharma-Led Initiative To Increase Access To Treatments 29/06/2018 Catherine Saez Early results of a biopharmaceutical companies-based initiative to encourage access to treatment in developing countries shows a focus on cancer, diabetes, and cardiovascular disease, through 62 programmes. The report, conducted by an independent observatory, provides key findings on several areas, including local priorities, and social inequity. Continue reading -> CDC Director Redfield: Long-Term Investment In Global Health Security Most Critical 14/06/2018 William New WASHINGTON, DC -- Recently named director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield told a gathering of global health experts this week that the most critical investment that can be made is in global health security, with the recent fast response to the Ebola outbreak in the Democratic Republic of the Congo setting the example. Continue reading -> Trump Declares Intent To Stop Pharma Companies From ‘Gaming’ Patent System 11/05/2018 William New US President Trump today declared in a White House speech his intent to "take steps" to lower drug prices by stopping "gaming of regulatory and patent processes by drug makers to unfairly protect monopolies," as well as increasing price transparency and promoting biosimilars and generics. But to do this, his administration will take on what it sees as "freeloading" on US innovation by foreign governments, and addressing "unfair" intellectual property and market access policies in trade agreements. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
US Releases New Medicare Drug Plan To “Pay The Prices Other Countries Pay” 26/10/2018 David Branigan The United States Department of Health and Human Services has released a new plan intended to reduce drug prices for some patients on Medicare, based on an international pricing index model. In his announcement of the plan, President Trump said the US would save money “for our seniors by paying the prices other countries pay. Nothing special, just the prices that other countries pay.” Continue reading -> Political Views And Vaccine Refusal Rates An Increasing Concern For Policymakers And Public Health Officials 13/07/2018 Tatum Anderson Or they should be. That’s the conclusion of a recent study published in the medical journal Vaccine. The study focused on political views of parents in the state of California, who had chosen not to vaccinate their nursery-school aged children. And it tracked the number of parents who had filed personal belief exemptions (PBEs), applications for permission to avoid vaccinations over a 5-year period to 2015. A disproportionate number of parents filing such forms were from Republican or conservative neighbourhoods, according to researcher Kevin A Estep, from the health administration and policy program at the university. Continue reading -> First Results Of Pharma-Led Initiative To Increase Access To Treatments 29/06/2018 Catherine Saez Early results of a biopharmaceutical companies-based initiative to encourage access to treatment in developing countries shows a focus on cancer, diabetes, and cardiovascular disease, through 62 programmes. The report, conducted by an independent observatory, provides key findings on several areas, including local priorities, and social inequity. Continue reading -> CDC Director Redfield: Long-Term Investment In Global Health Security Most Critical 14/06/2018 William New WASHINGTON, DC -- Recently named director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield told a gathering of global health experts this week that the most critical investment that can be made is in global health security, with the recent fast response to the Ebola outbreak in the Democratic Republic of the Congo setting the example. Continue reading -> Trump Declares Intent To Stop Pharma Companies From ‘Gaming’ Patent System 11/05/2018 William New US President Trump today declared in a White House speech his intent to "take steps" to lower drug prices by stopping "gaming of regulatory and patent processes by drug makers to unfairly protect monopolies," as well as increasing price transparency and promoting biosimilars and generics. But to do this, his administration will take on what it sees as "freeloading" on US innovation by foreign governments, and addressing "unfair" intellectual property and market access policies in trade agreements. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Political Views And Vaccine Refusal Rates An Increasing Concern For Policymakers And Public Health Officials 13/07/2018 Tatum Anderson Or they should be. That’s the conclusion of a recent study published in the medical journal Vaccine. The study focused on political views of parents in the state of California, who had chosen not to vaccinate their nursery-school aged children. And it tracked the number of parents who had filed personal belief exemptions (PBEs), applications for permission to avoid vaccinations over a 5-year period to 2015. A disproportionate number of parents filing such forms were from Republican or conservative neighbourhoods, according to researcher Kevin A Estep, from the health administration and policy program at the university. Continue reading -> First Results Of Pharma-Led Initiative To Increase Access To Treatments 29/06/2018 Catherine Saez Early results of a biopharmaceutical companies-based initiative to encourage access to treatment in developing countries shows a focus on cancer, diabetes, and cardiovascular disease, through 62 programmes. The report, conducted by an independent observatory, provides key findings on several areas, including local priorities, and social inequity. Continue reading -> CDC Director Redfield: Long-Term Investment In Global Health Security Most Critical 14/06/2018 William New WASHINGTON, DC -- Recently named director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield told a gathering of global health experts this week that the most critical investment that can be made is in global health security, with the recent fast response to the Ebola outbreak in the Democratic Republic of the Congo setting the example. Continue reading -> Trump Declares Intent To Stop Pharma Companies From ‘Gaming’ Patent System 11/05/2018 William New US President Trump today declared in a White House speech his intent to "take steps" to lower drug prices by stopping "gaming of regulatory and patent processes by drug makers to unfairly protect monopolies," as well as increasing price transparency and promoting biosimilars and generics. But to do this, his administration will take on what it sees as "freeloading" on US innovation by foreign governments, and addressing "unfair" intellectual property and market access policies in trade agreements. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
First Results Of Pharma-Led Initiative To Increase Access To Treatments 29/06/2018 Catherine Saez Early results of a biopharmaceutical companies-based initiative to encourage access to treatment in developing countries shows a focus on cancer, diabetes, and cardiovascular disease, through 62 programmes. The report, conducted by an independent observatory, provides key findings on several areas, including local priorities, and social inequity. Continue reading -> CDC Director Redfield: Long-Term Investment In Global Health Security Most Critical 14/06/2018 William New WASHINGTON, DC -- Recently named director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield told a gathering of global health experts this week that the most critical investment that can be made is in global health security, with the recent fast response to the Ebola outbreak in the Democratic Republic of the Congo setting the example. Continue reading -> Trump Declares Intent To Stop Pharma Companies From ‘Gaming’ Patent System 11/05/2018 William New US President Trump today declared in a White House speech his intent to "take steps" to lower drug prices by stopping "gaming of regulatory and patent processes by drug makers to unfairly protect monopolies," as well as increasing price transparency and promoting biosimilars and generics. But to do this, his administration will take on what it sees as "freeloading" on US innovation by foreign governments, and addressing "unfair" intellectual property and market access policies in trade agreements. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
CDC Director Redfield: Long-Term Investment In Global Health Security Most Critical 14/06/2018 William New WASHINGTON, DC -- Recently named director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield told a gathering of global health experts this week that the most critical investment that can be made is in global health security, with the recent fast response to the Ebola outbreak in the Democratic Republic of the Congo setting the example. Continue reading -> Trump Declares Intent To Stop Pharma Companies From ‘Gaming’ Patent System 11/05/2018 William New US President Trump today declared in a White House speech his intent to "take steps" to lower drug prices by stopping "gaming of regulatory and patent processes by drug makers to unfairly protect monopolies," as well as increasing price transparency and promoting biosimilars and generics. But to do this, his administration will take on what it sees as "freeloading" on US innovation by foreign governments, and addressing "unfair" intellectual property and market access policies in trade agreements. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Trump Declares Intent To Stop Pharma Companies From ‘Gaming’ Patent System 11/05/2018 William New US President Trump today declared in a White House speech his intent to "take steps" to lower drug prices by stopping "gaming of regulatory and patent processes by drug makers to unfairly protect monopolies," as well as increasing price transparency and promoting biosimilars and generics. But to do this, his administration will take on what it sees as "freeloading" on US innovation by foreign governments, and addressing "unfair" intellectual property and market access policies in trade agreements. Continue reading -> Posts navigation Older postsNewer posts